Vetanova Stock

Vetanova EV/FCF

Delisted

The EV/FCF (Enterprise Value to Free Cash Flow) of Vetanova (VTNA) as of Aug 7, 2026 is -0.27. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was -0.14 — a change of 92.31% (lower).

EV/FCF

-0.27

YoY

92.31%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Vetanova is 2026 -0.27 . EV/FCF (Enterprise Value to Free Cash Flow) of Vetanova was 2025 -0.14 . It decreases by 92.31% lower compared to the previous year.
Access this data via the Eulerpool API

Vetanova Stock analysis

What does Vetanova do? Vetanova Inc is a company that specializes in the production of veterinary medicines and has its roots in the animal health industry. It was founded in 2005 by a team of experienced veterinarians with the aim of improving the treatment of pets and livestock through the development of innovative products. Vetanova's business model is based on the manufacturing and marketing of veterinary medicines, as well as the sale of pet food and care products. The company's different divisions include both the development and production of prescription drugs and over-the-counter products, which are sold in specialty stores and online shops. Vetanova has specialized particularly in the development of medicines against infections, parasites, and inflammation. The company relies on a combination of traditional and modern manufacturing processes to bring high-quality products to the market. In addition to manufacturing medicines, Vetanova also offers a variety of products for the care and nutrition of pets. These include dietary supplements, pet care products, and specialized pet food tailored to their needs. As a company dedicated to the quality of its products and the health of animals, Vetanova works closely with veterinarians and breeders to ensure that its products meet high standards. In this regard, Vetanova also strives to intensify collaboration with scientific institutions to improve and further develop the effectiveness of its products. Animal welfare is also an important factor for Vetanova. The company advocates for the protection and well-being of animals and supports projects that help animals in need. In summary, Vetanova is a successful and renowned company that has specialized in the development and production of veterinary medicines since 2005. The company offers a wide range of products, including both prescription and over-the-counter products, targeting both pets and livestock. Vetanova is dedicated to the health of animals and focuses on collaborating with veterinarians and breeders to improve the effectiveness and quality of its products. Animal welfare and sustainability are other important aspects emphasized by Vetanova. Vetanova is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vetanova stock

EV/FCF (Enterprise Value to Free Cash Flow) of Vetanova is -0.27 in 2026.

EV/FCF (Enterprise Value to Free Cash Flow) of Vetanova changed from -0.14 to -0.27, representing a 92.31% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Vetanova since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Vetanova with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Vetanova

All Key Metrics — Vetanova